The Impact of Lymphadenectomy and Lymph Node Metastasis on the Outcomes of Radical Cystectomy for Bladder Cancer

European Urology

Volumn 55, Issue 4, 2009, Pages 826-835

  Karl, Alexander ^a   Carroll, Peter R ^b   Gschwend, Jürgen E ^c   Knüchel, Ruth ^d   Montorsi, Francesco ^e   Stief, Christian G ^a   Studer, Urs E ^f  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bladder cancer; Lymphadenectomy; Systematic review

Indexed keywords

BLADDER CANCER; CANCER INVASION; CANCER SURVIVAL; CYSTECTOMY; HISTOPATHOLOGY; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW;

CYSTECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 60249089201     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.01.004     Document Type: Review

References (56)

1. Bladder cancer. National Cancer Institute website. http://www.cancer.gov/cancertopics/types/bladder.
2. Prout G.R., and Marshall V.E. The prognosis with untreated bladder tumors. Cancer 9 (1956) 551-558
3. Abdel-Latif M., Abol-Enein H., El-Baz M., and Ghoneim M.A. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol 172 (2004) 85-89
4. Leissner J., Ghoneim M.A., bol-Enein H., et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171 (2004) 139-144
5. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 19 (2001) 666-675
6. Vazina A., Dugi D., Shariat S.F., Evans J., Link R., and Lerner S.P. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 171 (2004) 1830-1834
7. Mills R.D., Turner W.H., Fleischmann A., Markwalder R., Thalmann G.N., and Studer U.E. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 166 (2001) 19-23
8. Vieweg J., Gschwend J.E., Herr H.W., and Fair W.R. The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol 161 (1999) 72-76
9. Stenzl A, Cowan NC, De Santis M, et al. Guidelines on bladder cancer: muscle-invasive and metastatic. Arnhem, the Netherlands: European Association of Urology; 2008. http://www.uroweb.org/fileadmin/tx_eauguidelines/Muscle-invasive%20and%20Metastatic%20Bladder%20Cancer.pdf.
10. Mehrsai A., Mansoori D., Taheri M.M., Sina A., Seraji A., and Pourmand G. A comparison between clinical and pathologic staging in patients with bladder cancer. Urol J 1 (2004) 85-89
11. Paik M.L., Scolieri M.J., Brown S.L., Spirnak J.P., and Resnick M.I. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 163 (2000) 1693-1696
12. Shariat S.F., Palapattu G.S., Karakiewicz P.I., et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 51 (2007) 137-151
13. Tekes A., Kamel I., Imam K., et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol 184 (2005) 121-127
14. Setty B.N., Holalkere N.S., Sahani D.V., Uppot R.N., Harisinghani M., and Blake M.A. State-of-the-art cross-sectional imaging in bladder cancer. Curr Probl Diagn Radiol 36 (2007) 83-96
15. Gschwend J.E., Dahm P., and Fair W.R. Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 41 (2002) 440-448
16. Hautmann R.E., Gschwend J.E., de Petriconi R.C., Kron M., and Volkmer B.G. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 176 (2006) 486-492
17. Lerner S.P., Skinner D.G., Lieskovsky G., et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol 149 (1993) 758-764
18. Madersbacher S., Hochreiter W., Burkhard F., et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 21 (2003) 690-696
19. Fleischmann A., Thalmann G.N., Markwalder R., and Studer U.E. Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder. Am J Surg Pathol 29 (2005) 89-95
20. Powles T., Murray I., Brock C., Oliver T., and Avril N. Molecular positron emission tomography and PET/CT imaging in urological malignancies. Eur Urol 51 (2007) 1511-1521
21. Anjos D.A., Etchebehere E.C., Ramos C.D., Santos A.O., Albertotti C., and Camargo E.E. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. J Nucl Med 48 (2007) 764-770
22. Sherif A., Garske U., de La Torre M., and Thörn M. Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol 50 (2006) 83-91
23. Lerman H., Metser U., Lievshitz G., Sperber F., Shneebaum S., and Even-Sapir E. Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT. Eur J Nucl Med Mol Imaging 33 (2006) 329-337
24. Liedberg F., Chebil G., Davidsson T., Gudjonsson S., and Mansson W. Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer. J Urol 175 (2006) 84-88
25. Bellin M.F., and Roy C. Magnetic resonance lymphography. Curr Opin Urol 17 (2007) 65-69
26. Mills R.D., Fleischmann A., and Studer U.E. Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results. Surg Oncol Clin N Am 16 (2007) 233-245
27. Stein J.P. The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer. Curr Oncol Rep 9 (2007) 213-221
28. Abol-Enein H., El-Baz M., bd El-Hameed M.A., Abdel-Latif M., and Ghoneim M.A. Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study-a single center experience. J Urol 172 (2004) 1818-1821
29. Smith Jr. J.A., and Whitmore Jr. W.F. Regional lymph node metastasis from bladder cancer. J Urol 126 (1981) 591-593
30. Leissner J., Hohenfellner R., Thuroff J.W., and Wolf H.K. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85 (2000) 817-823
31. El-Shazli S., Anwar H., Ramzy S., and Al-Didi M. Extended lymphadenectomy to the lower paraaortic nodes during radical cystectomy. J Egypt Natl Canc Inst 16 (2004) 22-28
32. Shvetsov E.V. Anatomy and topography of external iliac lymph nodes in adults [in Russian]. Arkh Anat Gistol Embriol 100 (1991) 50-57
33. Dhar N.B., Jones J.S., Reuther A.M., et al. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder. BJU Int 101 (2008) 969-972
34. Poulsen A.L., Horn T., and Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 160 (1998) 2015-2019
35. Feinstein A.R., Sosin D.M., and Wells C.K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312 (1985) 1604-1608
36. Dhar N.B., Klein E.A., Reuther A.M., Thalmann G.N., Madersbacher S., and Studer U.E. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179 (2008) 873-878
37. Brossner C., Pycha A., Toth A., Mian C., and Kuber W. Does extended lymphadenectomy increase the morbidity of radical cystectomy?. BJU Int 93 (2004) 64-66
38. Stein J.P., Penson D.F., Cai J., et al. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 177 (2007) 876-881
39. Koren R., Paz A., Lask D., et al. Lymph-node revealing solution: a new method for detecting minute lymph nodes in cystectomy specimens. Br J Urol 80 (1997) 40-43
40. Vogel C., Kirtil T., Oellig F., and Stolte M. Lymph node preparation in resected colorectal carcinoma specimens employing the acetone clearing method. Pathol Res Pract 204 (2008) 11-15
41. Liedberg F., and Månsson W. Lymph node metastasis in bladder cancer. Eur Urol 49 (2006) 13-21
42. Yang X.J., Lecksell K., and Epstein J.I. Can immunohistochemistry enhance the detection of micrometastases in pelvic lymph nodes from patients with high-grade urothelial carcinoma of the bladder?. Am J Clin Pathol 112 (1999) 649-653
43. Kurahashi T., Hara I., Oka N., Kamidono S., Eto H., and Miyake H. Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II. Clin Cancer Res 11 (2005) 3773-3777
44. Retz M., Lehmann J., Szysnik C., et al. Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR. Eur Urol 45 (2004) 314-319
45. Marín-Aguilera M., Mengual L., Burset M., et al. Molecular lymph node staging in bladder urothelial carcinoma: impact on survival. Eur Urol 54 (2008) 1363-1372
46. Stein J.P., Cai J., Groshen S., and Skinner D.G. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 170 (2003) 35-41
47. Wright J.L., Lin D.W., and Porter M.P. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer 112 (2008) 2401-2408
48. Fleischmann A., Thalmann G.N., Markwalder R., and Studer U.E. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol 23 (2005) 2358-2365
49. Weingartner K., Ramaswamy A., Bittinger A., Gerharz E.W., Voge D., and Riedmiller H. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 156 (1996) 1969-1971
50. Herr H.W., Bochner B.H., Dalbagni G., Donat S.M., Reuter V.E., and Bajorin D.F. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167 (2002) 1295-1298
51. Cheng C.W., Ng C.F., Chan C.K., Wong W.S., Hui P.E., and Wong Y.F. A fourteen-year review of radical cystectomy for transitional cell carcinoma demonstrating the usefulness of the concept of lymph node density. Int Braz J Urol 32 (2006) 536-549
52. Kassouf W., Agarwal P.K., Herr H.W., et al. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol 26 (2008) 121-126
53. Roehrborn C.G., Sagalowsky A.I., and Peters P.C. Long-term patient survival after cystectomy for regional metastatic transitional cell carcinoma of the bladder. J Urol 146 (1991) 36-39
54. Vieweg J., Whitmore Jr. W.F., Herr H.W., et al. The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience. Cancer 73 (1994) 3020-3028
55. Herr H.W. Superiority of ratio based lymph node staging for bladder cancer. J Urol 169 (2003) 943-945
56. Herr H.W., and Donat S.M. Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol 165 (2001) 62-64